Raymond Owens, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5900 E University Ave, Suite 300, Pleasant Hill, IA 50327 Phone: 515-623-2600 |
Stacey L Milani, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 5900 E University Ave, Suite 300, Pleasant Hill, IA 50327 Phone: 515-643-2600 Fax: 515-643-4733 |
Whitney Milligan Waite, MD, MPH Pediatrics Medicare: Medicare Enrolled Practice Location: 5900 E University Ave Ste 300, Pleasant Hill, IA 50327 Phone: 515-643-2600 Fax: 515-643-4733 |
James Michael Metts, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 5900 E. University Avenue, Suite 300, Pleasant Hill, IA 50327 Phone: 515-643-2600 Fax: 515-643-4733 |
News Archive
Testicular cancer patients who do not respond to traditional therapy can be cured with high-dose chemotherapy and a stem cell transplant, according to an Indiana University School of Medicine report in the July 26 issue of the New England Journal of Medicine.
New research shows that asthmatics who have poor symptom control could be benefited by using a three-drug combination inhaler. The standard treatment for these patients is a two-drug combination of an inhaled corticosteroid (ICS) and a long acting beta 2 agonist (LABA). The third ingredient added to the mix is a long acting muscarinic antagonist, add the researchers. This combination successfully improved lung function and reduced exacerbations of asthma wrote the researchers.
Acknowledging the critical role of Centers for Disease Control and Prevention (CDC) guidelines in ensuring the safety and efficacy of H1N1 vaccinations, Carefx Corporation, a leading provider of interoperable workflow solutions to advance the quality and safety of patient care, today announced that Boston Medical Center (BMC) has deployed the Fusionfx Immunization Management portal designed to enter and track H1N1 vaccination administration history and support broad, community-wide immunization administration tracking.
Research scientist Christine Portfors will study how the brain chemical dopamine influences hearing with support from the National Institutes of Health. The work may ultimately lead to better therapies for people with hearing loss and communication problems.
Queen's University has announced it is to lead a -6 million European study to find new treatments for bowel cancer.
› Verified 3 days ago